EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS020-27541 
Organism
Homo sapiens 
Tissue/cell
CD34+ 
Coordinate
chr20:30197430-30200000 
TF binding sites/motifs
Number: 7             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
HES2MA0616.2chr20:30199311-30199321GGCACGTGCC+6.02
HES2MA0616.2chr20:30199311-30199321GGCACGTGCC-6.02
Nr2f6(var.2)MA0728.1chr20:30199388-30199403TGACCTTCTGACCTC-7.52
RARAMA0729.1chr20:30199385-30199403TCTTGACCTTCTGACCTC-7.51
STAT1MA0137.3chr20:30198568-30198579TTTCCAGGAAA+6.62
Stat4MA0518.1chr20:30198568-30198582TTTCCAGGAAAGGG+7.64
ZNF263MA0528.1chr20:30198607-30198628GGAGGAGCACAGGGAGGGGCG+6.05
Number of super-enhancer constituents: 29             
IDCoordinateTissue/cell
SE_02970chr20:30198290-30198767Bladder
SE_02970chr20:30199332-30199745Bladder
SE_23092chr20:30198143-30200173Colon_Crypt_1
SE_23905chr20:30198313-30199277Colon_Crypt_2
SE_23905chr20:30199346-30199605Colon_Crypt_2
SE_24856chr20:30198129-30199158Colon_Crypt_3
SE_24856chr20:30199310-30200138Colon_Crypt_3
SE_27857chr20:30191494-30200969Fetal_Intestine
SE_28873chr20:30191441-30200905Fetal_Intestine_Large
SE_31829chr20:30191527-30198255Gastric
SE_31829chr20:30198270-30199761Gastric
SE_33920chr20:30196505-30198178HCC1954
SE_33920chr20:30198212-30200846HCC1954
SE_34238chr20:30189210-30201146HCT-116
SE_34664chr20:30188903-30201189HeLa
SE_38269chr20:30190026-30200015HUVEC
SE_41187chr20:30191504-30197931Left_Ventricle
SE_41187chr20:30198022-30199309Left_Ventricle
SE_42444chr20:30198233-30199786Lung
SE_47160chr20:30189148-30200294Panc1
SE_48882chr20:30198252-30199227Right_Atrium
SE_50279chr20:30191498-30200037Sigmoid_Colon
SE_52484chr20:30191540-30200981Small_Intestine
SE_54437chr20:30197753-30199818Spleen
SE_55719chr20:30198018-30199221u87
SE_57184chr20:30197375-30198119VACO_400
SE_57184chr20:30198195-30200129VACO_400
SE_57391chr20:30198295-30199172VACO_503
SE_67492chr20:30198018-30199221u87
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 3             
ChromosomeStartEnd
chr203019829030199039
chr203019937130199990
chr203019780530197886
Enhancer Sequence
GATCTGCCCA CCTCAGCTTC CCGAAGAGCT GGGATTACAG ATGTAAGCCA CCGTGCCCGG 60
CCTGTGTTCA CTTTTCAGAT GAGAAAACGG AGGCATCAAA GAGGTGAGGT GACCCACCCA 120
AGGCCACATT GCACATTACC TTAGAGGACT TTCCAGAAAT CAGACTTGTC TAAATCAGGT 180
TTATGAGGGG CCTCATGTTC CCACAGTATG TCCAGTTTAT AAAGCCTTTC ATCTTATTTC 240
CAACTGAAAT CATACCTGGT CATTATATTT ATTTGTTTTA AAAGCATAAC TCAGATAAAT 300
GCAAGAAATA TACACATATC ACAATTTTTG CAACCCATAT TGGGGAATGT CTATTTTTTT 360
TTTTAAGACA GTTTTCCTCG TCACCCAGGC TGGAGTGCAA TGGGGCGATC TCGACTCAAC 420
CGCAACCTCC GCTTCCCAGT TTCAAGCAAT TCTTCTGCCT CAGCTTCCCA AGAAGCTGGG 480
ATTACAGGCA TATGCCAACA CGCCCAGCTA ATTTTTGTAT TTTTAGTAGA GACAGGGTTT 540
CACCATGTTT GCCAGGCTGC TCTCGAACTC CTGACCTCAG GTGATCTACC CTCCTCAGCC 600
TCCCAAAGTG CATGAGGCCA CCGTGCCCGG CTCTTTTTTT TTTTTTTTTT TTTTTTTTGA 660
GACAGAGTCT CGCTCTGTCG CCCAGGCTGG AGTGCAGTGG CGTGATCTTG GCTCATTGCA 720
ACCTCCGCCT CCCGGGTTCA AGCAATTCTC ATGCCTCAGC CTCCTGAGTA GCTGAGATTA 780
CAGACGCGCA CCACCACATC TGGCTAATTT TTATATATTT AGTAGAGACG GGGTTTCACC 840
ATGTTGCCCA GGCTGGCCTC GAACTCCTGA CCTCAGGTGA TCAGCCCTCC TCAACCTCCC 900
AAAGTGCTGG GATTACAGGC GTGAGCCACC ACACCCGACC CATGCCAGTC ACTCTTATTG 960
AGCACCAGGA ACTGCCAGCC AGAGAGAGCT CCCTGCTGCC CAGTGTCACA CACAGCAGGG 1020
CTTCCTGGTG GCAGGCAGGT CTCACATCCT AGCATGGCTG CCGGAAAGAA AGGAGGTGAG 1080
TCACAGGGCC AGGCCAGGAG CTGGGCGAGG CTGGGGCCAG GGTCCAGGCA GGCGCCACTT 1140
TCCAGGAAAG GGAAGGGAAG AGGAAACCAG AAGGCCAGGA GGAGCACAGG GAGGGGCGAG 1200
GGTGCCCTTA TCTCCCTGGA CCTGCCCTGG CTGGTGCTGC TTCCTGCTGC AACTCTTGCA 1260
AAACCTCGTT CCCAACGCTG TCCTCAAGCA GGGTGCCCCA GGCCAGTACA GGGTTGCATC 1320
AAGGCCTTGT GCAAGGGGGG TTAAAGGGAG GACAGTGGCT GGGAGCAAAG GCAGGGCAAG 1380
AGGCAAGGCA AATGCGGGTT CTAGGCCCAG TGCCACTTCT GGTTGGGCAC CTGCTTCACC 1440
TCCTGGGCTC TTAGGATCCC CAGCATTTTT TTTTTTTTTT TTGAGACGGA GTCTCACTCT 1500
GTTGCCAACC TCTGCCTCCT GGGTTCAAGC AATTCTCCTG CCTCAGCCCC TCCAGTAGCT 1560
GAGTCTACCG GTGTGCACCA CGACGCCCAG CAATTTTTGT ATTTTTAGTA GAGACAGGGT 1620
TTCTACATGT TGGCCAGGTT GGTCTCGAAC TACTGACCTC AGGTGATCCA CCTGCCTTGG 1680
CCTCCCAAAT TGTTGGGATT ACAGGTGTGA GCCACTGCAC CCTGCCATCC CCAGCATTTT 1740
TTTTTTTTTT TTTTTTTTGA GACAGAGTCT CCCTCTCTTG CTAGCCTGGA GTGCAGTGGC 1800
AGGAGCTCAG CTCACTGCAA CCTGTGTCTC CCAGGTTCAA GTGATTCTCC TGCCTCACCC 1860
TCCCAAGTAG CTGGGGTTAT AGGCACGTGC CACCACGCCC AGCTAATTTT TGTGTTTTTA 1920
GTAGAGACGG GGTTTCACCG TGTTGGCCAG GTTGGTCTTG ACCTTCTGAC CTCGTGGTCT 1980
GCCCGCCTTG GCCTCCCAAA GTGCTGGGAT TACAGGTGTG AGCCACCATG TCGCCCAGCC 2040
TCATTCCCAG CTTTTAAATG GGTGTTATAC TCACCGTTTT GAGGTTTCAG TGATATCATC 2100
CCAAACCTTT GCACTCCTCA AGCCTCAGGC TAGGCCATTG TACTTCTACC TGTGAAACTA 2160
GCCCCAACTG GTTCTTTCAA CAAATAGTTT ATAAAGCTTC TACAATATAC TAGGAACCGG 2220
GCCCCAGGAG TTAACAATTC AGATACAAAT TCTTGCAGTC TTGGAACTTA CATTCTTAGT 2280
GGGAGACACG CAGTAGATAA ATATGCAGAT GTGTAATCAG AGGTGCATTT ACCTGGAAAT 2340
TACTTAAGCT TAAACTTCAA GCCTCCTCAC ATGGAAAGAG TATCAGCCAT GTGTTAGCAT 2400
GATTTCTGTG TGTTTTGCAA GATTTGCAAA ATGTTGTATT CTTTTCCTTA GAGGCTGCAC 2460
AAACCTAGAT CCTCTTCTTT ATATATAGAC GAGACCGAGC AGGGCCCAAG CTTGAAGGCA 2520
TAGCTGCAGA AGACAAAGAA TCGTGTCTGT GGGTGCTGTT CGTTGCTTGG 2570